Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-60.84%Return on Equity
VS
Market
Sector
Industry
History
$ 43.56Close
$ 8.76 - $ 43.56 52-Week Range
Ticker Information
Ticker
MLYSCompany Name
MINERALYS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMINERALYS THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MLYS - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 313.55M | $ -190.77M | -60.84% |
| 3/31/2025 | $ 341.56M | $ -188.51M | -55.19% |
| 12/31/2024 | $ 191.26M | $ -177.81M | -92.97% |
| 9/30/2024 | $ 236.93M | $ -153.25M | -64.68% |
| 6/30/2024 | $ 290.1M | $ -119.67M | -41.25% |
| 3/31/2024 | $ 328.05M | $ -90.8M | -27.68% |
| 12/31/2023 | $ 241.15M | $ -71.9M | -29.81% |
| 9/30/2023 | $ 264.01M | $ -56.58M | -21.43% |
| 6/30/2023 | $ 285.01M | $ 0 | 0% |
| 3/31/2023 | $ 295.88M | $ 0 | 0% |
Key Performance Insights, Last 5 Years
- MINERALYS THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, MINERALYS THERAPEUTICS INC's average ROE has been -49.23%.
- The median ROE for MINERALYS THERAPEUTICS INC during this period was -48.22%
- MINERALYS THERAPEUTICS INC reached its highest ROE over the past 5 years at -21.43%.
- The lowest ROE recorded by MINERALYS THERAPEUTICS INC in the same timeframe -92.97%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for MINERALYS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -19.41M ] / Equity [ $ -22.93M ]
(=) ROE [ 0% ] MLYS - Return on Equity, Last 5 years
-92.97%
Minimum
Dec 31, 2024
-21.43%
Maximum
Sep 30, 2023
-49.23%
Average
-48.22%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |